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Abstract
Human endogenous retroviruses (HERVs) are spread throughout the genome and their long terminal repeats (LTRs)
constitute a wide collection of putative regulatory sequences. Phylogenetic similarities and the profusion of integration
sites, two inherent characteristics of transposable elements, make it difficult to study individual locus expression in a large-
scale approach, and historically apart from some placental and testis-regulated elements, it was generally accepted that
HERVs are silent due to epigenetic control. Herein, we have introduced a generic method aiming to optimally characterize
individual loci associated with 25-mer probes by minimizing cross-hybridization risks. We therefore set up a microarray
dedicated to a collection of 5,573 HERVs that can reasonably be assigned to a unique genomic position. We obtained a first
view of the HERV transcriptome by using a composite panel of 40 normal and 39 tumor samples. The experiment showed
that almost one third of the HERV repertoire is indeed transcribed. The HERV transcriptome follows tropism rules, is sensitive
to the state of differentiation and, unexpectedly, seems not to correlate with the age of the HERV families. The probeset
definition within the U3 and U5 regions was used to assign a function to some LTRs (i.e. promoter or polyA) and revealed
that (i) autonomous active LTRs are broadly subjected to operational determinism (ii) the cellular gene density is
substantially higher in the surrounding environment of active LTRs compared to silent LTRs and (iii) the configuration of
neighboring cellular genes differs between active and silent LTRs, showing an approximately 8 kb zone upstream of
promoter LTRs characterized by a drastic reduction in sense cellular genes. These gathered observations are discussed in
terms of virus/host adaptive strategies, and together with the methods and tools developed for this purpose, this work
paves the way for further HERV transcriptome projects.
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Introduction
The concept of endogenous retroviruses (ERV) dates back to the
1970’s and particle-budding observations in the years that
followed have gradually provided evidence that mammal genomes
serve as reservoirs for retroviral elements [1,2,3]. Later, the
sequencing of distinct species unveiled the contribution of the
ERV subset within transposable elements (TE), and highlighted in
particular a similar proportion of retrovirus-like sequences in
human and mouse genomes (8–10%) [4,5,6,7]. The endogenous
retrovirus pool is thought to originate from ancestral and
independent infections within the germ line [8,9], before complex
re-infection, retro-transposition, propagation and error-prone
steps occurred during evolution. In humans, the definition of at
least 31 HERV families is commonly accepted in reference to
putative ancestors [10]. As a result, each family contains tens to
thousands of distinct loci scattered throughout the human genome.
To date, all the HERV elements that have been characterized
are defective for viral replication. Nevertheless, the discovery that
some HERV proteins may contribute to biological events has
quickly generated interest in open reading frame (ORF) sequences.
The Syncytin-1 and Syncytin-2 envelope glycoproteins are
encoded by full-length HERV sequences belonging to the
HERV-W and HERV-FRD families, respectively and, through
cell differentiation mechanisms, these proteins are presumably
essential for human placentation (reviewed in [11]). Syncytin-1 is
also associated with epithelial cancers [12,13] and was recently
detected in the peripheral blood of leukemia and lymphoma
patients [14]. Among the HERV-K HML-2 family, full-length
proviruses can encode either Rec or Np9 proteins, which are
known to interact with cellular partners and ultimately may affect
cancer signaling pathways [15,16,17,18]. Although HERVs match
the self-antigen concept, the immune response directed against
HERV-K HML-2 Env and Gag proteins is remarkably detectable
in the blood of patients with seminoma up to six months before
diagnosis [19,20,21,15] and thus may form a basis for molecular
tools for early germ cell tumor detection.
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be reduced to ORF and putative coding genes (in reference to
oncoviruses) since TE also contribute to genome plasticity.
Duplication of Alu sequences, recombination, and transduction
of LINE elements may have led to multigenic families, gene
duplication and exon shuffling [22,23,24]. In particular, the long
terminal repeat (LTR) sequences of HERV elements may be the
source of inter-element recombination phenomena resulting in
chimerical proviruses, tandem structures and solitary LTRs
[25,26,27]. Current estimates indicate that the human genome
harbors around 200,000 HERVs (excluding MaLR), mainly
composed of sequences resembling LTRs [5,28,29]. Taking into
account that LTRs exert natural transcription functions within a
retrovirus, it is likely that some have now retained the potential to
act as regulatory elements [30,31].
In this context, many studies have established a role for LTRs as
a promoter [32,33,34,35,36,37,38], bidirectional promoter
[39,40], enhancer [41,42], polyadenylation signal [43] and
antisense transcript negative modulators [44] of cellular genes in
different biological contexts (for a full review see [45]). On the
basis of serendipitously and case-by-case identifications, knowledge
of functional interactions between HERV elements and cellular
environment has gradually grown and is increasingly based on
systematic approaches. As different works now estimate that more
than 50% of human genes use alternative promoters [46,47], the
importance of accurately identifying distinct HERV elements in
transcriptome-wide studies, documenting their expression in a
variety of biological contexts and finally assessing the question of
their regulation in connection with their genomic environment is a
strong argument for the need for a HERV transcriptome project
[48].
Over the last 10 years, most of the attempts for HERV
expression measurement used RT-PCR techniques either to focus
on a specific locus [49,50,51,52,53] or to evaluate general trends
within HERV families or genera [54,55,56,57]. Yet the inherent
limitations in the development of reliable PCR systems to
discriminate individual HERV elements in a holistic approach
require fairly laborious work [58,48]. On the other hand, methods
based on expressed sequence tags (ESTs) provided a more
comprehensive view of the HERV transcriptome but generally
ran into trouble for identifying the unique genomic source of
expression [59,60].
We previously developed an early high-density microarray
generation dedicated to the HERV transcriptome, given promis-
ing results in terms of tropism and individual locus identification
notwithstanding high risks of cross-reactions [61]. Following this
attempt, in this work, we introduced a new methodology suitable
for repeated element probe design aiming to minimize cross-
reactions. At the same time, we expanded the content of the chip
to 6 HERV families: HERV-W, HERV-H, HERV-E 4.1, HERV-
FRD, HERV-K HML-2 and HERV-K HML-5, providing the
user with a collection of 2,690 distinct proviruses (complete or
partial) and 2,883 distinct solo LTRs ready for expression
monitoring. Additionally, independent probesets within U3 and
U5 regions made it possible to assign a function (i.e. promoter or
polyA) to 1,513 LTRs. We used this next generation microarray to
gain insights into the HERV transcriptome using a composite
panel of 40 normal and 39 tumor RNA samples. We found that
HERV expression patterns are highly dependent on tissue type
and differentiation state and accordingly we established a list of
potential HERV biomarkers. We also identified 326 and 209
LTRs with putative promoter and polyA activity, respectively, and
highlighted extensive operational determinism for active LTRs.
We finally emphasized the trend for promoter LTRs to be
associated with an upstream 8 kb zone characterized by a poor
sense cellular gene density, compared to silent and polyA LTRs.
Taken together, these data allowed us to discuss the adaptive
relationship between viruses and host and to prepare a first draft of
the HERV transcriptome that could help renew the role of the
HERV repertoire in the context of what was improperly named
‘junk’ DNA.
Results
Detection of the HERV Transcriptome
We constructed a database grouping 10,035 distinct HERV
elements that belong to 6 HERV families (Table 1a), and we used
it as an input collection for the design of a new and suitable
HERV-dedicated microarray, called HERV-V2. For this purpose,
we developed a scoring function which assesses the ability of a 25-
mer probe/target pair to hybridize in Affymetrix-based technology
format. This function, referred to as EDA+, allowed us to exclude
candidate probes that did not meet specificity criteria. The
resulting HERV-V2 chip can discriminate 5,573 distinct HERV
elements (23,583 probesets) that can reasonably be assigned to a
unique genomic position, including functional U3/U5/gag/pol/
env parts, either for provirus structures or solo LTR elements
(Table 1b).
As an initial view of the HERV transcriptome, we performed a
study based on a diversified panel composed of both normal and
tumor tissues, including testis, colon, ovary, prostate, breast,
uterus, lung and placenta samples. Noteworthy, all samples except
placenta are matched normal/tumor tissues obtained from the
same individual. The set of data revealed transcriptional activity
for 1,718 distinct HERV elements (Table 1c), which is about one
third of the HERV-V2 chip contents and may suggest a similar
proportion of active elements among the human genome. We then
sought (i) to determine whether HERV expression varies
depending on the tissue and thus follows tropism rules or not,
(ii) to find out the extent to which HERV elements are sensitive to
the state of differentiation and may serve biomarker research, (iii)
to gain insight into transcriptional mechanisms in the light of
genomic environment and (iv) to reinforce the comprehensive role
of the HERV repertoire in our biology.
Characterization of the HERV Transcriptome
Tropism of Active HERVs. To determine whether the
nature of a tissue affects HERV expression, we classified active
probesets according to their expression pattern. Although a large
proportion shows either no expression or weak unclassifiable
signals (data not shown), 10 expression profiles were obtained from
partitioning clustering (Figure 1A). The final sizes and the
resolving power vary from one profile to another in accordance
with data structure. Among the 10 profiles, 2 main types should be
distinguished, whether the profile involves only one tissue, or more
than one. In profiles 1, 2, 3, 4, 6, 7 and 8, the probesets have a
single-tissue expression and consequently can be considered to be
tissue-state sensitive. On the other hand, profiles 5, 9 and 10 are
dedicated to active probesets expressed in more than one tissue
(even being expressed in all tissues such as in profile 10), and thus
must reflect a more complex tropism. A detailed list of all HERV
loci composing the groups of expression, including genomic
coordinates, is provided in Table S3.
In an attempt to unveil a particular behavior in such expression
patterns, the number of probesets is summarized taking into
account the 6 HERV families (Figure 1B). Interestingly, some
profiles coincide with a predominant family representation. This is
the case among the colon tumor group (profile 2) where the
HERV Transcriptome Landscape
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5 that is entirely described by the HERV-E 4.1 family, and for
profile 9 which mostly involves HERV-W probesets.
Differential Expression Associated with Tissue State
Changes. To gain insight into the variation of expression
associated with tissue state, we performed supervised statistical
analysis in pairwise tissues using the SAM method with FDR
correction. In order to easily compare the results from the different
tissues, we used a high and constant false discovery rate
(FDR=20%). Each paired tissues (i.e. normal tissue versus
adjacent tumor tissue) gives an independent number of differen-
tially expressed probesets, ranging from zero (in uterus, data not
shown), to 1,092 in testis (Figure 2A). Additionally, the lists are
compared to highlight tissue-specific probesets.
To get a better view of the relevance of the results obtained with
the SAM-FDR procedure, we drew scatter plots of normal versus
tumor expression values for each tissue pair (Figure 2B). The
density of plots, the relative amount of tissue-specific probesets (in
red) as well as the deviation from the reference straight line
together serve to distinguish valuable probesets from non-relevant
results. Thereby colon, testis and in a lesser extent ovary and lung
involve numerous probesets showing both significant variation of
expression and tissue specificity. A list of all the HERV loci that
show differential expression together with their associated genomic
coordinates is provided in Table S3.
LTR Functions. To approach the question of HERV
transcription mechanisms, we focused on LTR signals. In the
context of the distribution of a substantial number of retroviral
sequences throughout the human genome, we assessed the
question of LTR functions regardless of the original provirus
structure. Based on the fact that one LTR can theoretically assume
different functions depending to its environment, we systematically
tested whether the transcription initiates, ends within the LTR, or
Table 1. Detection of the HERV transcriptome.
Repertoire Elements
e HERV-W HERV-H HERV-E 4.1 HERV-FRD
HERV-K
HML-2 HERV-K HML-5 Total
Genome
a solo LTRs 464 1079 158 1259 1000 87 4047
complete or partial
proviruses
823 1492 455 349 2685 184 5988
59 LTRs
d 128 1036 41 36 52 22 1315
39 LTRs
d 219 1062 39 45 2482 22 3869
gag
d 199 1093 246 88 117 126 1869
ppol
d 234 0 0 96 0 0 330
pol
d 0 1315 330 75 155 147 2022
env
d 240 1173 67 154 2548 97 4279
Chip
b solo LTRs 432 553 120 1189 512 77 2883
complete or partial
proviruses
304 1354 427 218 215 172 2690
59 LTRs
d 120 444 29 33 29 18 673
39 LTRs
d 171 485 29 43 85 19 832
gag
d 162 787 228 80 85 125 1467
ppol
d 222 0 0 0 0 0 222
pol
d 0 1154 307 35 93 135 1724
env
d 205 513 63 127 66 97 1071
Transcriptome
c solo LTRs 100 209 30 251 199 19 808
complete or partial
proviruses
101 587 91 39 75 17 910
59 LTRs
d 26 154 10 8 10 4 212
39 LTRs
d 43 182 10 11 35 7 288
gag
d 12 202 51 4 15 4 288
ppol
d 80 0 0 00 8
pol
d 0 170 28 1 9 2 210
env
d 49 71 5 16 12 2 155
aNumber of distinct genomic HERV loci included in HERV database HERV-gDB3. The database contains 6 HERV families with unequal input. The search for distinct
elements belonging to each family is performed by systematic BLAST genome coverage, allowing a maximum 20% divergence with prototype elements.
bNumber of distinct genomic HERV loci present in the chip. Each element of the database is processed through home-made EDA+ algorithm to find probes that match
optimal hybridization criteria. The candidate probes are then checked against the entire human genome (NCBI 36/hg18) using the KASH algorithm to control their
cross-hybridizing ability and non-specific sequences are removed. Probes are ultimately assembled into probesets to discriminate individual genomic HERV sequences.
Differences between database and chip mark the success in designing HERV-specific probes and probesets. For clarity, the probeset content is not detailed.
cHERV transcriptome results: number of active elements in all tissues tested. After the experiments were normalized using the COMBAT method and an arbitrary
positive threshold was applied (value=100), elements that are active in at least one tissue are enumerated.
dSubsets of complete or partial proviruses.
eOne element can be composed of several probesets.
doi:10.1371/journal.pone.0040194.t001
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PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e40194Figure 1. Tropism of active HERVs. (A) Active probesets ‘cluster’ into 10 expression profiles. The final number of profiles is estimated after
iterative corrections combining Euclidean partitioning algorithm and fine manual adjustment steps. Box plots indicate the distribution and the
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PLoS ONE | www.plosone.org 4 June 2012 | Volume 7 | Issue 6 | e40194median of probeset intensity, whiskers are 5–95 percentiles, dots show outliers. The order of profiles is not important. (B) Profile description. Each
profile refers to a specific cluster of tissues, and involves a number of probesets detailed by families. By definition, a probeset is classified in a unique
profile, except for the asterisk (*) where a single probeset is willingly shared by both profiles 3 and 10.
doi:10.1371/journal.pone.0040194.g001
Figure 2. Differential expression induced by tissue state changes. (A) Pairwise analysis. For each paired tissue, the SAM-FDR method is
applied and leads to the identification of a number of probesets that show significant differential expression (FDR =20%). The red number in
brackets indicates how many differential expressed probesets are specific to the tissue. Uterus normal versus tumor comparison gives no result and
consequently does not appear in the table. (B) Scatter plots of expression values. Normal versus tumor normalized expression values of differential
expressed probesets are draw for each tissue pair. The statistically significant absence of differential expression is represented by the diagonal line
(y=x). Red plots refer to tissue-specific probesets (previously mentioned using red numbers in bracket in Figure 2A).
doi:10.1371/journal.pone.0040194.g002
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process (Figure 3A).
We used the dichotomy of signals acquired from probesets
distributed along U3 and U5 regions to assign the functions: U3-
associated negative signals and U5-associated positive signals for
promoter, U3 positive signals and U5 negative signals for polyA,
U3 and U5 double positive signals for readthrough. Loci which
exhibited double negative U3 and U5 signals were classified as
silent (expression level cutoff=50 for negative signal). Expression
levels between 50 and 100 delineate an indeterminate grey area
where a function is assigned only if the ratio between U3 and U5
signals is greater than 4 (see legend of Figure 3A for details). Due
to the general LTR sequence homology and the large share of
partial and complex structures, only a small fraction of LTRs meet
the requirement to infer a function. These LTRs are referred to as
‘attributable LTR’ - aLTR in the text - in Figure 3B and represent
one third of the chip LTR content.
Of all the tissue samples tested, we finally identified a total of
326 distinct autonomous ‘promoter’ LTRs (21% of aLTR) and
209 distinct ‘polyA’ LTRs (13% of aLTR). Very surprisingly, there
is no overlap between these two LTR lists except one which
belongs to the grey area. This highlights that active LTRs cannot
switch from promoter to polyA function even if the tissue changes,
which we will refer to as operational determinism. To enhance this
opinion we repeated LTR function analysis using a completely
different set of data coming from cell lines that were subject to
chemical and oncogenic transformations (data not shown). Using 6
different cell lines, we found a parallel list of 67 promoter and 46
polyA LTRs and still no overlap between promoter and polyA
LTRs exists. Moreover, the cell culture-derived list closely matches
the results from tissues: among the 113 (67 promoters +46 polyA)
active LTRs unambiguously characterized from the cell culture,
only 7 LTRs did not intersect with the 535 LTR list (326
promoters +209 polyA) characterized from tissues. This means
that less than 2% of new characterizations have been gained by
diversifying biological records. Consequently, this result prompts
us to conclude that we have delineated a stable pool of active and
functional LTRs.
Most of the function characterizations concern solo LTRs with
247 promoter solo LTRs and 151 polyA solo LTRs (26% of
aLTR), but the function distribution seems to be unbalanced
between families: although there is generally a low number of
output cases, we observed for instance that the HERV-K HML-5
family has no occurrence of polyA solo LTRs, and we noted that
the HERV-K HML-2, HERV-W, HERV-E 4.1 and HERV-FRD
families have more promoter solo LTRs cases than polyA solo
Figure 3. LTR functions. (A) Schematic view of LTR structure and associated theoretical transcription events. Top to bottom: the LTR is a natural or
alternative promoter when the transcription starts between U3 and R/U5; the LTR ends an upstream transcription event by the addition of polyA tail
at the end of the R region; the transcription passes through the LTR with no incidence in the progression of the polymerase, which results in the
detection of U3, R and U5 transcripts. Rules for function assignment are promoter:U 3 2/U5+; polyA:U 3 +/U5-; readthrough:U 3 +/U5+ and silent:U 3 2/
U5-; with expression levels: + .100; - ,50. Expression levels between 50 and 100 delineate an indeterminate grey area where a function is assigned if
the ratio between U3 and U5 is greater than 4 (for instance U3=80 and U5=321 is counted as promoter). Otherwise, the LTR function is declared to
be unknown. (B) Assignment of functions.
a,b,c Loss of information from HERV database to understandable functions.
a Summary of Table 1a
b
Summary of Table 1b
c Enumeration of LTRs whose function is attributable, i.e. defined as LTR combining both complete structure on the genome
and existing probesets on the chip, that can ultimately allow a discrimination between U3 and U5 expression signals.
doi:10.1371/journal.pone.0040194.g003
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to involve a greater amount of polyA solo LTRs compared to
promoter solo LTRs. Focusing on provirus structures, we
identified 34 promoter 59LTRs and 30 polyA 39LTRs. In some
cases, we associated both 59 promoter and 39 polyA activities
within a given provirus. We also discovered 45 promoter 39LTRs
and 28 polyA 59LTRs.
Besides these 34% comprehensive active aLTR, we also showed
that a high proportion of the LTR population always remains
silent (672 cases; 44% of aLTR). In addition to that, we identified
a smaller number of readthrough LTRs (25 cases; ,2% of aLTR).
Validation Analyzes. We first compared our results with
previously published data focusing on the HML-2 family as this
family has been widely studied using various methodologies. We
included data derived from EST study [59], genomic repeat
expression monitoring (GREM) for experimental genome-wide
identification of promoter-active repetitive elements [62], PCR-
sequencing [48] and array-based approaches [61]. Of the 327
HML-2 elements we analyzed, 25 elements were shared by at least
one of the previous studies (Table S4). On this subset, Affymetrix-
based format analysis gave 64% and 63% correlation with the
EST approach and the PCR-sequencing-based study, respectively.
A poor correlation of 19% was observed with GREM.
To confirm the tropism of active HERV, we then tested
whether the elements we classified within expression groups using
HERV-V2 correlate with tissue-related EST libraries. A fairly
clear enrichment of the expected EST population was observed in
the case of colon, ovary and placenta and can also reasonably be
claimed in the case of testis taking into account that testis-
associated HERV sequences were initially distributed into
3 expression groups (Table S5). In contrast, results depicted for
lung and prostate were not supported by ESTs, probably due to an
overall less-pronounced expression level of related HERV
elements. We then picked 33 candidate loci and designed PCR
primer pairs which were evaluated for sequence specificity using
high resolution melting and sequencing (see Materials and
Methods, RT-PCR). Eighteen highly specific primer pairs
corresponding to 8 loci were eventually selected and tested on
samples (Table S6). An overall good correlation of 0.926 (min
0.606; max 0.998) between arrays and RT-PCR was observed,
essentially confirming the attributed tropism (Figure S2). Never-
theless, unexpected expression was found twice for two HERV-H
proviruses, in cancerous colon in addition to the expected
expression in tumor testis, and in cancerous ovary in addition to
the expected expression in tumor colon.
The LTR functions were assessed using U3 versus U5 RT-PCR
assays. Using this strategy, we previously validated the promoter
function of 6 loci expressed in testicular cancer identified by the
first version of the HERV microarray [61], which was confirmed
in this study (data not shown). Such a strategy was used again and
confirmed two new tropism-related promoters (200261_w and
1100414_2) as well as one ubiquitous promoter (2000062_2) as
presented in Figure S3. Then, to broaden the scope of such
analysis, we sought to confirm LTR functions by analyzing the U3
versus U5 distributions of LTR-associated ESTs for a subset of the
HERV-W family consisting of 21 proviruses and 110 solo LTRs or
LTRs associated with truncated proviruses. We focused on the
HERV-W family because it contains the ERVWE1 domesticated
locus in which the 59LTR promoter and the 39LTR polyA
functions have been exhaustively demonstrated [63,64,65,66,61].
Results are depicted in Table S7 and alignments are provided in
Figure S4. In brief, only 17 loci among the 131 loci analyzed
exhibited significant LTR-associated ESTs and only 16 loci are
ultimately interpretable. 8 EST-deduced functions (7 promoters, 1
polyA) were consistent with those we identified following
microarray results. Two other promoter functions were compat-
ible with an upstream alternative transcription initiation site (see
locus 1200505_w and locus 600462_w in Table S7). One
additional promoter function was plausible (locus 400207_w)
although an alternative splicing event excluding U3 could be
involved. Finally, one readthrough identified using microarray
(locus 700126_w) could be classified either as polyA or read-
through with regard to EST data. Four comparisons were
discrepant, opposing readthrough to promoter function, and
putatively identifying a removal of the U3 region in mRNAs due
to a splice occurrence. Altogether, the overall correlation between
array and EST-deducible functions ranged between 50% and
75%.
Influence of the Genomic Environment. We extended our
investigation to the genomic environment encompassing the
newly-identified functional and silent LTRs. For each LTR, we
performed a search for gene presence and %GC content in the
surrounding 50 kb, starting from the limits of the LTR. When the
position of the LTR overlaps with the position of the gene, the
LTR is counted as intronic. The total number of neighboring
genes normalized by the initial number of LTRs gives a gene
density ratio detailed for each category (Figure 4A). The gene
density ratio is almost 1.5 times higher for active LTRs than for
silent LTRs although the %GC barely varies. Meanwhile, the
proportion of intronic LTRs is largely in favor of antisense
representation for all categories of LTRs.
The case of intergenic LTRs is subject to a more detailed
description in Figure 4B. For promoter, polyA and silent LTR
groups, a cumulative gene distribution function is drawn upstream
(59) and downstream (39) of the LTR limits (vertical bar)
emphasizing whether the genes found away from the LTR have
the same orientation as the LTR (sense) or not (antisense). This
revealed a strikingly low occurrence of genes in sense orientation
up to 8 kb upstream of promoter LTRs while the upstream 8 kb
for silent and polyA LTRs shows no difference regarding the gene
orientation. Besides, the downstream environment also appears to
be linked to the LTR function but in a kind of mirror situation in
which the sense genes occurrence apparently rises faster than for
antisense genes in the downstream 8 kb zone of silent LTRs
compared to promoter and polyA LTRs.
Lessons Learned from the HERV Transcriptome. The
different results were finally used to construct a comparative view
of HERV genome and transcriptome. To achieve this goal, we
used the term ‘HERV genome’ to refer to the entirety of our
HERV genome database content (i.e. 6 HERV families), and we
opposed the HERV transcriptome resulting from our experiments
(Figure 5). Since the HERV-V2 content reflects the success in
designing specific probes and probesets, which varies from one
family and one element to another, we had to apply correction
factors to raw transcriptome results. Accordingly, the following
outcome must be regarded as an extrapolation.
The first observation tends to show there is no difference
between the contribution of each family to genome and
transcriptome sharing (Figure 5A). However, the transcription
seems to be impacted by the structure of HERV elements in a
trend that aims to reduce proviral gene expression (30% to 16%)
(Figure 5B). More flagrantly, the genomic environment appears to
exert a major influence as the expression of HERV elements that
map close to human genes (,10 kb) is twice constricted and, at the
same time, the expression of intronic HERV sequences in sense
orientation reduces dramatically (9% to 3%) (Figure 5C). Focusing
on LTRs and regardless of the tissue tested, almost 50% of the
LTR elements remain silent, while active LTRs are roughly
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(Figure 5D). We also identified very few cases of readthrough
LTRs (3%).
Discussion
HERV Transcriptome Views
We provided a microarray-based description of the HERV
transcriptome based on the analysis of a set of cancerous and non-
cancerous tissues that reflect a range of diversity. Different works
have been conducted to discover the contribution of HERV to the
human transcriptome [38,60,59,62,48,61]. In this study we
identified 1,718 active HERV elements suggesting that about
30% of the retroviral sequences spread across the genome are
transcribed. Despite the fact that it is usually thought that HERVs
colonize the genome and consequently are tightly controlled to
avoid gene disruption [67], our observation of a substantial basal
HERV transcriptional activity is partly supported by others. In
2008 Conley et al. analyzed high-throughput expression data to
claim that transcribed HERV sequences correspond to 1.16% of
Figure 4. Genomic environment of functional and silent LTRs. (A) Overview of genomic and chromatin composition (%GC) of functional LTR
neighborhood. For all promoter, polyA, readthrough and silent LTRs, the number of neighboring genes in the surrounding +/250 kb is obtained
from NCBI 36/hg18 using annotations from the RefGene table (UCSC), then the DNA sequences are extracted in silico for %CG content calculation.
The table includes the number of intronic functional LTRs, defined as LTRs that overlap gene limits (NCBI 36/hg18 RefGene table), and ends with the
number of intergenic LTRs. Sense: LTR and gene are in the same orientation; antisense: LTR and gene are in opposition. (B) Genomic environment for
intergenic functional LTRs. Genes in the same orientation (sense) or in opposition (antisense) with the LTRs are counted in the case of promoter, polyA
and silent intergenic LTRs. Read-through LTRs are not included as their number, which is too low, does not fit with the representation. Vertical bar
centered on zero should be interpreted as an ellipse of the LTR sequence. Away from the bar, the cumulative gene occurrence is shown up to +/
225 kb starting from the LTR limits. Curve tendencies beyond 25 kb do not change significantly and are not represented.
doi:10.1371/journal.pone.0040194.g004
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approximately 15% of HERV sequences are active. Previous
analyses of HERV activity based on ESTs led Oja and colleagues
to estimate that 7% of the HERV sequences are transcribed [68].
More generally, the fact that the human genome might be more or
less pervasively transcribed, including sequences previously
Figure 5. Genomic and transcriptomic projections of the HERV repertoire. (A) HERV families. The 6 HERV families studied in this work are
voluntarily depicted as 100% of HERV human genome, in the proportions described in Table 1a. The transcriptome picture is obtained from results
detailed in Table 1c after applying a correction factor that takes into consideration chip content in Table 1b.( B) HERV structures. Solo LTR and
proviruses account for 100% of the HERV genome in the proportion described in Table 1a. The transcriptome part is based on Table 1c after
correction taking into consideration the chip content presented in Table 1b. (C) HERV environment. A systematic search for genomic environment is
performed for elements present in the HERV database (genome) and the active elements described in Table 1c (transcriptome). The proportion of the
3 types of LTR is based on Table 1a and the transcriptome from Table 1c after correction using Table 1b. (D) The role of junk DNA. HERV sequences
represent approximately 8% of the human genome. The graph of LTR functions is based on Figure 3B after a correction based on the number of
attributable functions and chip content.
doi:10.1371/journal.pone.0040194.g005
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project and led to the proposal of the ‘warehouse’ concept for
natural selection [69]. This suggests how HERV may regulate
human transcription on a large scale.
EST data appear to be insufficient to describe the transcrip-
tional activity of HERVs and therefore to unambiguously
characterize promoter functions, as previously discussed [60,48].
Moreover, for the most active HERV elements, Oja reported
hundred to thousand-fold over-representation of pol and env
regions (as opposed to LTRs). Such poor EST detection in either
59 or 39 LTRs could be due to the nature of the EST methodology
which may be sensitive to low level of expression or end-location of
secondary structured LTRs on mRNA or even the occurrence of
polypurine tracks within retrovirus genes [70]. Notably, EST
strategy failed to identify ERVWE1/Syncytin-1 39LTR as a polyA
signal as discerned using HERV-V2, although the full-length
Syncytin-1-containing polyadenylated cDNA has been isolated
[63]. Nevertheless, focusing on the 22 well-described HML-2
elements we shared with the EST study conducted by Stauffer, we
obtained a correlation of 64%. Similarly, the circumscribed EST
analysis conducted on HERV-W elements confirmed up to 75% of
our promoter elements.
HERV Tropism and Implication in the Biomarkers Field
The HERV transcriptome presented herein was generated
using a set of tissues selected in order to support the hypothesis
that individual HERV can serve the biomarker field. Among
cancerous and non-cancerous tissues, we characterized expression
patterns supporting that testis and placenta are privileged places of
HERV expression. Syncytin-1, a functional envelope glycoprotein
belonging to the HERV-W family, is expressed in the placenta and
in the testis [63,71,49,61]. Syncytin-2, a member of the HERV-
FRD family, takes part in the placenta expression cluster
[72,49,73] and numerous envelope and capsid elements related
to the HERV-K HML-2 family formed the testicular tumor group
as described previously [2,74,75,19,76]. In a recent work, we
reported the expression of 6 HERV-W elements in testicular
tumor using an early version of HERV chip [61]. This second
generation of the HERV chip allowed to confirm the overexpres-
sion of 5 out of 6 elements (the 6
th locus belongs to the grey area as
defined above) and, at the same time, we identified numerous new
HERV-W elements specific to the testicular cancer sample with
high expression levels. The association of HERV-H elements with
colon cancer [59,77,78,79] and the finding of HERV-E 4.1
sequences in a group composed of prostate, uterus and ovary
samples has also been reported [61] and is confirmed here. Taken
together, these findings argue in favor of non-random behavior of
HERV elements and families and thus suggest a strong HERV
tropism acting within human organs.
In line with this idea, we focused on differential expression
between normal and tumor tissues in pairwise analyses. The use of
SAM-FDR gold standard statistical tests [80] led to the
identification of a variable number of elements that are sensitive
to the state of differentiation. We took the responsibility of false-
positive results using a high FDR value but we also assumed that,
by using a test with low stringency, we did not miss any interesting
elements. Testis here again appears to be the most predisposed
context to HERV differential activity with more than 1,000 DEP
composed of almost two-thirds of tissue-specific probesets. Notably
we highlighted a significant number of probesets with strong and
specific expression variation between normal and cancerous colon
samples. The RT-PCR experiments we set up to validate HERV
tropism and differential expression showed that HERV-V2 overall
trends are accurate. Nevertheless, discrepancies between micro-
array and RT-PCR have also been observed, which may reflect a
lower sensitivity of the chip as opposed to RT-PCR, e.g. due to the
intrinsic sensitivity of the whole transcriptome amplification or to a
target-dependent unbalanced amplification. For ovary and lung
analysis, although the number of DEP seems impressive, only a
few probesets deviate from low values. In addition, we did observe
variable levels of genomic DNA contamination within lung
samples, which may have biased the result of analysis. Altogether,
although promising, the transfer of these results into biomarkers
will require further clinical studies based on relevant dedicated
procedures [81], notably taking into account inter-individual
variations.
Specialization of Human LTR Function
After a retrovirus has integrated the host genome, its two
flanking LTR sequences are strictly identical, yet the alteration of
HERV structures and the genetic drift over time may provide a
favorable context for both natural and alternative LTR functions.
As a result in the current human genome, the estimated 200,000
HERV LTRs can be seen as a wild collection of promoter and
polyA elements. Based on this concept, we identified 326 promoter
LTRs, 209 polyA LTRs, 25 readthrough LTRs and 672 silent
LTRs among the 1513 evaluated LTRs. Confirmation analysis
based on HERV-W-associated ESTs revealed that putative
splicing events excluding U3 regions occurred in some cases,
which may lead to an overestimation of promoter functions.
Conversely, we did not assign promoter functions to LTRs lacking
probes in U3 but exhibiting high positive signals in U5. In
particular, we identified 34% of active HML-2 promoters. This is
slightly less than the GREM experimental method that showed at
least 50% of HERV-K HML-2 LTR serve as in vivo promoters
[62,36]. Some of the elements identified with GREM were found
in our study but it is somewhat disturbing to find only a poor
correlation (19%). This could be due to inter individual variations
among tissue samples in both studies, as only one testicular
parenchyma was used to implement the GREM methology [62].
Alternatively, given that GREM is a PCR-based method, the
analysis of transcribed HERV sequences can be more sensitive
than with microarrays but conversely can be complicated by
recombination events during PCR [58].
Most of the function characterizations concern solo LTRs
(398 out of 535; 74%). In detail, we characterized 247 promoter
solo LTRs and 151 polyA solo LTRs. If we look at solo LTRs
regardless of their family, we are inclined to consider that these
structures, originating from recombination phenomena, are more
likely to exert promoter rather than polyA functions. However, the
relative amount of promoter and polyA solo LTRs varies
remarkably from one family to another. Within the HERV-K
HML-5 family, we only characterized promoter solo LTRs. The
HERV-W, HERV-E 4.1, HERV-FRD and HERV-K HML-2
families similarly showed a predominant set of solo LTRs with
promoter functions. It is noteworthy that among the 6 HERV
families we studied, the oldest, HERV-H, gives the most
significant example of polyA solo LTR overrepresentation. The
observed biases in solo LTR specialization may result from an
intrinsic property of the natural history of each family, as
exemplified in a different context by the LINE-1-mediated
spreading of a significant proportion of the HERV-W family
[82]. Alternatively we cannot exclude an orientated and irrevers-
ible genetic drift within LTR sequences. Further functional
comparative analysis of evolutionary-conserved solo LTRs may
permit to address these hypotheses.
We also examined the 59 end of the 45 promoter 39LTR
elements. The proportion of 59-truncated structures in this subset
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when a function can be attributed, the existing 59LTR is silent.
This observation can suggest a loss of fixation of transcription
factors. Indeed, different works on proto-oncogene activation
induced by retrovirus insertion have showed that the 39LTR can
initiate alternative transcription of cellular genes only if the
insertion was accompanied by an inactivation of the 59LTR of the
provirus [83], a concept referred to as promoter occlusion [84].
Thus, the description of 45 promoter 39LTRs in this study appears
consistent with the concept of promoter occlusion.
Astonishingly, promoter and polyA lists have no LTR in
common, a strong trend we called operational determinism. This
was observed using both the 79 normal et cancerous tissue panel
and the 6 cell lines. Thus, despite environmental changes over
time, active LTRs seem to feature unique specialized functions.
Nevertheless, HERV-W-associated ESTs showed that in some
contexts, only a readtrough phenomenon can replace or be added
to promoter or polyA function. This finding is compatible with
operational determinism but suggests the presence of weak
promoter or polyA activities. In addition, attempts to validate
LTR functions by leveraging EST data have faced the possibility
of alternative transcription initiations. Indeed, alternative initiation
sites have been proposed for the promoter of ERVWE1 following
mung bean nuclease protection assays [65]. These two alternative
sites are located 71 bp and 75 bp upstream from the site we
defined by RACE as the R border [63,61], respectively. Moreover,
due to genetic drift, the location of initiation sites within HERV
LTRs may be more flexible than for exogenous retroviruses.
HERV Functions and Genomic Environment
Gene density in the environment of active promoter LTRs is
significantly higher than for silent LTRs as previously observed for
the HML-2 family [36]. Notably, this behavior was also shared by
LTRs exhibiting polyA function. Such observations could be
interpreted in two ways: either chromosomal regions with high
transcriptional activity promote HERV activity as a side effect
(e.g.: bringing transcription factors together with DNA strand
opening), or there is a functional contribution of active LTRs to
human gene regulation in a way that would be of benefit to the
genome. Conversely, exclusion of methylated silent LTRs from
gene-rich regions preclude methylation spreading and then
silencing of conventional genes as previously suggested for
transposable elements [85]. The set of 99 intronic LTR elements
investigated here presented a 3.7 fold bias in favor of antisense-
oriented insertion, similar to the 2 to 4.5 range previously
described [86,87]. As previously proposed, this suggests a strong
selection against LTR elements in the sense direction and
consequently argues that LTRs found in the same transcriptional
orientation are much more likely to have a detrimental effect [87].
It is noteworthy that the antisense orientation bias appears similar
for silent and transcriptionally active LTRs. Regarding surround-
ing genes, this may reflect an overall weak transcriptional activity
as observed for a set of proviruses and solo LTRs belonging to the
HERV-W family [88]. Alternatively this could represent substan-
tial and therefore gene-independent transcription events in altered
cellular contexts.
Among the 1133 intergenic LTR elements, 288 (25%) were
promoter LTRs, 184 (16%) polyA LTRs and 639 (56%) silent
LTRs. Comparison of the gene environment of those intergenic
LTRs highlighted two points. Unexpectedly, an approximate 8 kb
interval upstream of intergenic promoter LTRs was characterized
by a drastic under-representation of sense genes. This result was
considered relevant due to the significant number of LTRs
(n=228) and the absence of LTR-associated multigene families
which may skew the results. This suggests that a sense-intergenic
promoter LTR can only survive at a certain distance of a sense
gene, otherwise it would have a detrimental effect on the gene.
Such a location may contribute to the usage of acceptor donor
sites together with alternative polyA signal which may alter the
original transcript as proposed for intronic elements [87]. Second,
a mirror situation consisting in an 8 kb window was observed
upstream from silent LTRs, showing a decrease in antisense genes
compared to sense genes. Although no obvious explanation can be
provided to date, it is striking to note that such a symmetrical 8 kb
region was recently shown to correspond to the maxima of LTR
density around transcription start site of tissue-specific genes [89].
Conclusion
This microarray-based approach unveiled the expression of
1,718 distinct HERV loci and identified 326 promoter LTRs and
209 polyA LTRs in a broad range of tissues. Further systematic
quantitative analysis is required to gain insight on the relative
variation of expression of HERV sequences and their adjacent
cellular genes. In particular, looking at different stages of cell
differentiation may accelerate the identification of alternative
promoters as already documented for a subset of genes in the
mouse embryo [90].
In addition to the preservation of transcription factor binding
sites, two important features determining the control of HERV
expression consist of the LTR methylation status
[91,92,93,94,61,95] and the chromatin context associated to post-
translational histone modifications [95]. Locus-specific LTR
hypomethylation was observed both during placental development
[91,92,93] and in testis and colon cancers [94,61,95]. Thus, such
whole transcriptome approach together with LTR function
identification and further characterization of associated epigenetic
marks may help to discriminate between statu quo, conflict and
cooperation, the components of a many-facetted relationship
between retrotransposons and their metazoan hosts.
Materials and Methods
Chip Design
HERV database. A database for genomic HERV elements
was constructed following a 4-step process: (i) for each HERV
family, we defined a prototype by choosing the most representative
and complete HERV element present in the human genome. (ii)
Functional U3/U5/gag/pol/env parts were labeled on the
prototypes. (iii) These sequences were then used as an input
reference library for RepeatMasker [96] (see the details of the
prototypes in Table S1). The search for HERV functional
sequences was extended to the entire human genome (NCBI
36/hg18) allowing a maximum 20% divergence with prototype
sequences. (iv) The functional sequences identified were lastly
assembled into annotated HERV elements and were implemented
in an owner database, so-called HERVgDB3. HERVgDB3
contains 10,035 distinct HERV elements belonging to 6 HERV
families, including complete and partial proviruses (Table 1a).
Probeset Design
The probe design steps aimed ultimately to define probesets for
the functional parts of each HERV element that belongs to
HERVgDB3. We first generated all possible and overlapping 25-
mer tracks for any given HERV sequence of HERVgDB3, leading
to an initial pool of candidate probes. We then evaluated the cross-
hybridization risk of each candidate probe using local alignment
versus the entire human genome (NCBI 36/hg18) as a model of
hybridization, supported by an internally developed alignment
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instability induced by any mismatch within the hybridization
between probe and target. Using EDA+, the impact of mismatches
is cumulative and modulated regarding their type, their position
and the size of the interval between two mismatches. A threshold
on the cumulative weight is then defined to consider the
hybridization as probable or not. Note that no specific thermo-
dynamic parameter was added to the model. The relevance of this
score was evaluated independently (data not shown). EDA+ was
applied to any local alignment between a candidate probe and the
human genome, computed using the KASH algorithm [97].
Probes that meet the alignment-EDA+ criteria were definitively
selected to enter the design process. This last step finally grouped
the selected probes in order to constitute probesets for any given
functional part of the HERV elements collection. When more
than 10 probes can be used to create a probeset, we make a
selection to obtain a homogeneous distribution of probes along the
functional part.
Custom HERV GeneChip Microarray
The custom HERV GeneChip integrates 23,583 HERV
probesets (88,592 probes) and can discriminate 5,573 distinct
HERV elements, composed of complete and partial proviruses
(Table 1b). In addition to the HERV repertoire, a set of mismatch
declinations (37,200 probes), initially based on 19 perfect match
(PM) probesets belonging to the commercial Affymetrix
HG_U133_PLUS2 chip, serves to evaluate and improve the
EDA+ hybridization scoring function (data not shown). The
standard Affymetrix control probes for unbiased amplification and
hybridization were also included in the microarray.
Sample Description
Tissue samples and cell lines. Matched-pair tumor/
normal RNA samples of colon (3), breast (8), ovary (3), uterus (3)
and prostate (1) were purchased from Clinisciences. Additional
First Choice human tumor/normal RNA samples of colon (1),
ovary (1), uterus (1), testis (1), lung (1) and prostate (2), plus normal
placenta sample (1), were obtained from Life Technologies. The
Centre de Ressources Biologiques of Nancy provided epidermoid
carcinoma and normal adjacent lung RNA samples (9) and the
Centre Hospitalier Lyon-Sud performed macro dissections on
radical prostatectomy specimens (5) to isolate cancer tissue from
normal tissue. Details on samples are provided in Table S2.
The human prostate epithelial cell line RWPE1 and the
chemically stressed-derived WPE1-NA22, WPE1-NB14, WPE1-
NB11, WPE1-NB26 [98] as well as the v-Ki-Ras-transformed
RWPE2 [99] cell lines were obtained from the CelluloNet of the
UMS3444/US8 BioSciences Gerland Lyon-Sud.
Ethical considerations. The human tissue specimens pro-
vided by the Centre Hospitalier Lyon-Sud and by the Centre de
Ressources Biologiques of Nancy were obtained in compliance
with the ICH-GCP regulations, current European and French
legislations. A ‘non-interventional’ biomedical research protocol
for tissue samples conservation after a prostate surgery has been
set-up at the Centre Hospitalier Lyon-Sud with the approval of the
Ethics Committee in Lyon (CPP Sud-Est 2). Therefore, patients
admitted to the urology department in the Centre Hospitalier
Lyon-Sud were informed and gave voluntary, signed informed
consent prior to any tissue sample conservation and for research
use. Patients admitted to the Nancy Hospital were informed that
their sample tissue after the lung surgery will be conserved at the
Centre de Ressources Biologiques de Nancy for research use
according to the French bioethics law (2004). Clinisciences and
Life Technologies signed an agreement to ensure that the tissue
samples were obtained in compliance with ICH-GCP standards.
Molecular Biology Analysis
RNA extraction. RNA was extracted from macro-dissected
radical prostatectomies following the Trizol protocol (Invitrogen)
and was purified on Rneasy columns (Qiagen). The quality of all
RNA samples was assessed with the Bioanalyser 2100 capillary
electrophoresis device using the RNA Nano Chips kit (Agilent).
Target amplification, labeling and microarray
hybridization. cDNA synthesis and amplification were per-
formed using 50 ng of RNA, using the WT-Ovation RNA
Amplification System kit (Nugen). Briefly, amplification was
initiated both at the 39 end and randomly throughout the whole
transcriptome, and this was followed by reverse transcriptase/
RNAse H mix step before SPIA linear and single strand
amplification. Amplified ssDNA products were purified using the
QIAquick purification kit (Qiagen), total DNA concentration was
measured using the NanoDrop 1000 spectrophotometer (Termo
Scientific) and the product quality was checked on the Bioanalyser
2100. Two micrograms of purified ssDNA were fragmented into
50–200 bp fragments by DNAseI treatment and were 39-labeled
using a terminal transferase recombinant kit (Roche). The
resulting target was mixed with standard hybridization controls
and B2 oligonucleotides following the recommendations of the
supplier. The hybridization cocktail was heat-denatured at 95uC
for 2 minutes, incubated at 50uC for 5 minutes and centrifuged at
16,000 g for 5 minutes to pellet the residual salts. The HERV
GeneChip microarrays were prehybridized with 200 mlo f
hybridization buffer and placed under stirring (60 rpm) in an
oven at 50uC for 10 minutes. The hybridization buffer was then
replaced by the denatured hybridization cocktail. Hybridization
was performed at 50uC for 18 hours in the oven under constant
stirring (60 rpm). Washing and staining were carried out according
to the protocol supplied by the manufacturer, using a fluidic
station (GeneChip fluidic station 450, Affymetrix). The arrays
were scanned using a fluorometric scanner (GeneChip scanner GS
3000, Affymetrix).
Real-time PCR. A set of locus-specific PCR primers was
designed using Primer3 and the NCBI Primer-BLAST software
and then checked in silico at UCSC (http://genome.ucsc.edu).
Primers were ordered from Eurogentec. For each individual PCR
system, a range of amplifications, followed by High Resolution
Melting (HRM) analysis and product sequencing, was performed
on genomic DNA to control the specificity of the products and to
determine optimal experimental melting temperature (Tm). For
each tissue, individual samples were pooled in order to compare
results from RT-PCR with the data from microarrays. 50 ng of
total RNA of each sample were DNAse-treated and reverse-
transcribed using the QuantiTec Reverse Transcription Kit
(Qiagen). Reverse-transcriptase-free reactions were carried out to
verify the absence of contaminating genomic DNA. SYBR green
experiments were set up using the Type-it HRM PCR kit (Qiagen)
in 10 mL final reaction volume with 5 mM primers and a 20-fold
dilution of the cDNA. PCR amplifications were carried out in
Rotor-disc 100 wrapped discs devised for the Rotor Gene Q
(Qiagen). Housekeeping genes G6PD, GAPDH and HPRT were
analyzed in the same experiment as the target transcripts.
Amplifications of cDNA were performed as follows: a 5-min
denaturation step at 95uC, followed by 45 cycles (95uC for 10 s,
Tm for 30 s, 72uC for 10 s) and HRM analysis (from 65uCt o
95uC, 0.1uC increments every 2 s) to control the product purity.
Each reaction was performed in duplicate. The second derivative
method was used to assess the amplification efficiency (Eff).
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DCt (DCt=Ctmin–
Ctsample). All data were normalized by the geometric mean of the
RLE of the three housekeeping genes.
Bioinformatics
Chip analysis. The quality control (QC) of the microarrays
was assessed using the standard Affymetrix controls to verify that
the chips met the criteria. In addition, the dataset was explored to
highlight unexpected batch effects and to correct them before
statistical analysis. The distributions of intensities for probes and
probesets were plotted to test different putative covariate effects
(e.g.: dates of amplification and hybridization, people in charge of
the experiment, lots of reagents). The following representations
were used: the log intensity value distribution (density plots and
box plots), the median absolute deviation (MAD) versus the
intensity median (MAD-Med plots), the background plots and
nuse plots and finally the relative log expression (RLE) plots. A
strong batch effect related to the experimental operator was
identified, as well as residual batch effects related to the
amplification dates within each operator. A customized pre-
processing strategy was thus selected to correct these technical and
undesired effects.
The data pre-processing included a background correction
based on the tryptophan probe baseline signal, followed by
normalization and summarization steps involving a double batch
effect correction. In brief, the background of each chip was
estimated as the 15
th percentile of the intensity values of the
tryptophan probes, then the robust microarray averaging (RMA)
process [100] was applied within each operator batch using the
configuration of quantile normalization followed by median polish
summarization. This process was applied independently for each
amplification date batch. After that, a two-step combining batches
(COMBAT) method [101] was applied, first within each operator
dataset in order to merge the date effects of a given operator, and
second within the entire chips set in order to merge the operator
datasets together (see Figure S1). The COMBAT method
constructs a model for each gene, formally written as:
Yijg~mgzXjbgzcigzdigeijg
Yijg is the signal measured for the gene g when the sample j is
processed in the batch I; mg is a mean expression level for the gene
g; we considered a single biological covariate X (here a qualitative
variable including the origin and the state of the tissue); bg defines
the level of differential expression related to biological categories
(the parameter we are looking for); parameters cig and dig are the
additive and multiplicative error components that define the batch
i (they are gene-specific) and eijg is the error that follows N(0, sg).
After all the chips were normalized, expression values of
individual chips were grouped into sets of samples as described in
Table S2. If no precision is given, all the results illustrated and
discussed in this study are based on the values of the sets of
samples.
Partitioning clustering was applied to the normalized expression
values using a Euclidean distance function algorithm to determine
similarities between observations. The final number of clusters was
decided after iterative corrections combining algorithm auto-
decisions and fine adjustments through direct observations of the
resulting dataset arrangement. The minimum number of probesets
required to form an expression cluster was empirically set at 6.
The search for differentially expressed genes (DEG) implied a
classical significant analysis of microarray (SAM) procedure [80]
followed by a false discovery rate (FDR) correction [102]. The
dataset was filtered to exclude the probesets for which expression
values were less than 2
6 in all tissues. A FDR cut-off of 20% was
applied.
Genomic environment. Homemade perl scripts were devel-
oped to request and extract information from the human genome
build NCBI 36/hg18 and the RefGene annotation table (UCSC).
Gene density and %GC content calculation were evaluated by
default in the +/250 kb surrounding environment, starting from
the HERV element ends.
Expressed Sequenced Tag (EST) analysis. The blastn
algorithm (NCBI blastn v.2.2.25) was used to compare HERV
sequences to EST libraries. A cut-off of 97% was retained as a
compromise between the extreme similarity existing between loci
of the same family and the polymorphism in the human
population, ranging from 1 out of 0.31 kb in repeats to 1 out of
1.8–2.0 kb in coding regions (Nickerson, 1998}. If no precision is
given, the default parameters used for alignment were: alignment
length .200 bp; EST/sequence alignment coverage .85%.
Software and data. QC, pre-processing and DEG analysis
were performed using R statistical software [103], packages from
the Bioconductor project [104] and homemade R packages. The
clustering algorithm used for this study is implemented in Partek
Genomics Suite 6.5. Geneious 5.0 was used for primer design and
EST analysis. The complete experimental set comprises 113
microarrays. Affymetrix data files (.cel) are available upon request.
Supporting Information
Figure S1 Effect of RMA-COMBAT normalization. Dis-
tribution of intensities within the dataset before (upper part) and
after (lower part) RMA-COMBAT normalization. Each boxplot
represents a single chip and the colors refer to experimental
batches.
(PDF)
Figure S2 Correlations between microarray and RT-
PCR results. Normalized values of microarray and RT-PCR
experiments are given for 12 independent HERV sequences that
belong to 8 distinct HERV loci. Correlations close to 1 indicate a
strong positive linear relationship and therefore confirm the
findings. Correl = Covmicroarray;RT-PCR/(sdmicroarray*sdRT-PCR).
(PDF)
Figure S3 RT-PCR analyses of LTR promoter functions.
The promoter activity of 3 independent LTRs was evaluated in
RT-PCR. Relative expression of U5 vs U3 is given by FcU5/U3=
(EffU3
CtU3)/(EffU5
CtU5). Values greater than 1 indicate a promoter
activity. An asterisk (*) highlights tissues for which the promoter
activity has been unequivocally found using the microarrays. In
the particular case of 1100414_2 no probeset was defined within
the LTR and consequently the promoter activity in testicular
tumor could not be detected using microarrays.
(PDF)
Figure S4 Pictures illustrating alignments of HERV-W
loci with their best EST counterpart. Each alignment is
designated by the name of the locus as it stands on the microarray,
followed by the name of the most similar EST. The alignment
explicitly states the retroviral structure including LTR U3, R and
U5 subdomains, as well as flanking regions. Probes defined on the
array are indicated by grey arrows. The sequence used for the
query is represented as well as the EST retained for analysis, as
developed in Table S7. Accession number and EST count are
shown. Arbitrary blue numbering of HERV subdomain and the
aligned EST together with blue vertical bars are indicated when
required to facilitate the reading, e.g. clones overlapping U5 and
59 flanking region for 400207_w-AI738459.jpg. Best score EST
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(700341_w-ERVWE1_3LTR.jpg) LTRs of the ERVWE1 locus
are included to highlight the limits of information provided by
ESTs.
(PDF)
Table S1 HERV prototypes used for the construction of
HERV-gDB3. Accession numbers, genomic localizations and the
limits of the functional region within the prototype sequences (U3,
R, U5, gag, pol env) are given for the 6 HERV families studied.
a
for HERV identification and gene cutting out.
b for LTR sub
region cutting out.
(PDF)
Table S2 Biological samples included in the study. List
of biological samples included in the study (samples) and used in
the composition of analysis groups (set of samples). Information on
pathological status, age and sex are provided when available.
Matched tumoral/normal samples are indicated (paired with). An
asterisk (*) highlights samples that were not used for the
microarray study.
(PDF)
Table S3 Genomic coordinates of active and functional
HERV sequences. Genomic coordinates refer to the human
genome version NCBI 36/hg18. Each HERV locus is designated
by a single identifier (locus id). The table summarizes the different
observations mentioned in the study, i.e. whether the locus shows
expression patterns (tropism), is differentially expressed between
normal and cancer samples (DGE) or exhibits functional LTRs
(LTR functions). Two ‘x’ in the ‘‘LTR functions’’ box associated
with one locus reflect distinct functions for each LTR of the same
provirus.
(XLS)
Table S4 Identification of HML-2 repetitive elements
characterized by independent methods. From left to right
the genomic location (NCBI 36/hg18), the individual HML-2
locus sequence name, the tropism of expression deduced from the
microarrays, the differential expression and the LTR functions as
depicted in Table S3, the references from which data were
obtained taking into consideration either EST analysis [59],
genomic repeat expression monitoring (GREM) for experimental
genome-wide identification of promoter-active repetitive elements
[62], PCR-sequencing [48] or array-based approach [61] are
given. The original designation of the HERV loci is given for each
study. We added April 2012 EST query information obtained
using the method developed in Table S7. Statistics concerning this
analysis are given at the bottom of the table and include, for each
study, the number of elements, the number of shared elements, the
number of active elements and the correlation between our work
and each individual study.
(XLS)
Table S5 Matching of tissue-specific HERV sequences
with Expressed Sequenced Tag (EST) databases. The
CleanEST database [105] was used to retrieve ESTs associated
with tissues of interest in order to construct 6 reference EST
groups: colon (311122 ESTs), lung (441913 ESTs), ovary (123944
ESTs), placenta (321881 ESTs), prostate (69860 ESTs) and testis
(264243 ESTs). Each EST group was blasted against the HERV
sequences composing the expression profiles shown in Figure 1,
following the procedure detailed in the EST analysis part of the
materials and methods section. Hits were normalized by the total
number of HERV loci of the expression profile and by the total
number of ESTs forming the reference group. The ranking of the
value is associated with a color code highlighting the enrichment of
tissue-associated ESTs: green (1/6), yellow (2/6) and red (.2/6).
(PDF)
Table S6 Primers used for RT-PCR experiments.
Forward and reverse primer sequences used for RT-PCR analyses.
The Tm of each primer pair was determined as described in the
related materials and methods section. The domain of application
is indicated (normalization, tropism, promoter function).
(PDF)
Table S7 Identification of Expressed Sequenced Tags
(ESTs) putatively associated with active HERV-W repet-
itive elements. We used Megablast to compare HERV
sequences to EST libraries using Geneious 5.0 software and
NCBI libraries. A cut-off of 97% was retained as a compromise
between the extreme similarity existing between loci of the same
family and the polymorphism in the human population ranging
from 1 out of 0.31 kb in repeats to 1 out of 1.8–2.0 kb in coding
regions [106]. From left to right, the genomic location (NCBI 36/
hg18), the individual HERV-W locus sequence name, the tropism
of expression deduced from the microarrays, the differential
expression and the LTR functions as depicted in the Table S3, the
LTR associated structure (i.e: provirus, solo LTR, partial provirus
with either 59 or 39 LTR), the EST scores, the reference accession
numbers of the ESTs, the EST length in bp, the EST coverage of
the LTR query (i.e: 100% or numbering when ,100%), the LTR-
element covered regions (i.e: U3, R, U5, gag, pol, env, 59 or 39
flanking region), the information concerning the additional
coverage of clones and the existence of additional clones in
flanking regions, the previous identification and designation of the
locus, the EST-associated proposed function, and the name of the
pictures illustrating alignments of HERV loci with their best EST
counterpart as detailed in Figure S4 are given. Parameters used for
Megablast query with Geneious 5.0 are indicated at the bottom of
the table, as well as statistics concerning the query and a color
code highlighting the correlation between array and EST LTR-
deduced functions.
(XLS)
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